Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease.

Autor:	Sugiura, Hiroyuki, Sezaki, Nobuo, Ishikawa, Tatsunori, Kuroi, Taiga, Okamoto, Sachiyo, Nomura, Naho, Masunari, Taro, Nakasako, Yukio, Kiguchi, Toru, Tanimoto, Mitsune
Předmět:	CHRONIC lymphocytic leukemia CHRONIC kidney failure VENETOCLAX TREATMENT effectiveness TUMOR lysis syndrome
Zdroj:	Clinical Case Reports; Apr2022, Vol. 10 Issue 4, p1-4, 4p
Abstrakt:	Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoclax. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.